Boyle Robert J, Robins-Browne Roy M, Tang Mimi L K
Asthma, Allergy and Immune Disorders Group, Murdoch Childrens Research Institute, Royal Children's Hospital, Victoria, Australia, and the Department of Microbiology and Immunology, University of Melbourne, Victoria, Australia.
Am J Clin Nutr. 2006 Jun;83(6):1256-64; quiz 1446-7. doi: 10.1093/ajcn/83.6.1256.
Probiotics have been advocated for the prevention and treatment of a wide range of diseases, and there is strong evidence for their efficacy in some clinical scenarios. Probiotics are now widely used in many countries by consumers and in clinical practice. Given the increasingly widespread use of probiotics, a thorough understanding of their risks and benefits is imperative. In this article we review the safety of probiotics and discuss areas of uncertainty regarding their use. Although probiotics have an excellent overall safety record, they should be used with caution in certain patient groups-particularly neonates born prematurely or with immune deficiency. Because of the paucity of information regarding the mechanisms through which probiotics act, appropriate administrative regimens, and probiotic interactions, further investigation is needed in these areas. Finally, note that the properties of different probiotic species vary and can be strain-specific. Therefore, the effects of one probiotic strain should not be generalized to others without confirmation in separate studies. Careful consideration should be given to these issues before patients are advised to use probiotic supplements in clinical practice.
益生菌已被提倡用于预防和治疗多种疾病,并且有强有力的证据表明它们在某些临床情况下具有疗效。目前,益生菌在许多国家被消费者广泛使用,并应用于临床实践。鉴于益生菌的使用日益广泛,全面了解其风险和益处势在必行。在本文中,我们回顾了益生菌的安全性,并讨论了其使用方面存在不确定性的领域。尽管益生菌总体上具有良好的安全记录,但在某些患者群体中应谨慎使用,尤其是早产或有免疫缺陷的新生儿。由于关于益生菌作用机制、合适的给药方案以及益生菌相互作用的信息匮乏,这些领域需要进一步研究。最后需要注意的是,不同益生菌种类的特性各不相同,且可能具有菌株特异性。因此,在未经过单独研究证实之前,一种益生菌菌株的效果不应推广至其他菌株。在临床实践中建议患者使用益生菌补充剂之前,应仔细考虑这些问题。